Keywords: glucagon-like peptide-1, diabetes mellitus, Alzheimers disease, Parkinsons disease, cognition Introduction Type 2 diabetes mellitus is a group of metabolic diseases characterized by hyperglycemia caused by relatively insufficient insulin secretion
While the Bridge is an important milestone, it should also be a catalyst for creating a permanent pathway to comprehensive obesity care within Medicare and across private insurance as well." Novo Nordisk is actively working with CMS, healthcare professionals, pharmacists, and patient advocacy organizations to support implementation and help ensure patients can access the medicines they need
Potential Applications in the Podiatry Setting While large-scale clinical trials are still limited, heres where BPC-157 and other peptides may find their place in foot care: Chronic plantar fasciitis unresponsive to conservative care Degenerative Achilles tendinopathy Partial ligament injuries that dont require surgery but need help healing Diabetic wound care when healing is stalled Adjunct to regenerative therapies such as laser, shockwave, or platelet-rich plasma Safety and Considerations Peptides like BPC-157 are generally well-tolerated, with few reported side effects
J.AkerstromV.PanW
On one side, pharmaceutical companies are pushing GLP-1 receptor agonists like semaglutide as the only solution for obesity